We are live on ! Find out more
XBIO icon

Xenetic Biosciences
XBIO

19 hedge funds and large institutions have $235K invested in Xenetic Biosciences in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $198K → $235K (+$37.7K)

0% more funds holding

Funds holding: 19 → 19 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.08% less ownership

Funds ownership: 0.46% → 0.38% (-0.08%)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$25.6K
2
TSS
Two Sigma Securities
New York
+$9.81K
3
Simplex Trading
Simplex Trading
Illinois
+$660
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$97
5
Wells Fargo
Wells Fargo
California
+$5

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$29.9K
2
Renaissance Technologies
Renaissance Technologies
New York
-$21.3K
3
Jane Street
Jane Street
New York
-$11.3K
4
HF
HRT Financial
New York
-$9.22K
5
Citadel Advisors
Citadel Advisors
Florida
-$7.86K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$40K -$21.3K -4,389 -31%
Vanguard Group
2
Vanguard Group
Pennsylvania
$39.4K -$29.9K -6,164 -39%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$37.7K -$383 -79 -0.9%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$32.1K +$25.6K +5,278 +211%
HF
5
HRT Financial
New York
$15K -$9.22K -1,900 -34%
State Street
6
State Street
Massachusetts
$14.3K – – –
JEST
7
JTC Employer Solutions Trustee
Jersey
$11K – – –
TSS
8
Two Sigma Securities
New York
$8.21K +$9.81K +2,022 New
SPIA
9
Steward Partners Investment Advisory
New York
$7.71K – – –
Northern Trust
10
Northern Trust
Illinois
$7.21K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$6.74K -$7.86K -1,620 -50%
E
12
Ergoteles
New York
$5.26K -$2.94K -606 -32%
TRCT
13
Tower Research Capital (TRC)
New York
$5K – – –
GVAG
14
Great Valley Advisor Group
Delaware
$4.3K – – –
Morgan Stanley
15
Morgan Stanley
New York
$1.2K -$1.47K -302 -51%
NC
16
NewSquare Capital
Pennsylvania
$106 – – –
Fidelity Investments
17
Fidelity Investments
Massachusetts
$89 +$97 +20 +1,000%
Wells Fargo
18
Wells Fargo
California
$43 +$5 +1 +10%
Jane Street
19
Jane Street
New York
– -$11.3K -3,977 Closed
Simplex Trading
20
Simplex Trading
Illinois
– +$660 +136 New

XBIO Hedge Fund Activity: Q1 2023 in Review

19 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q1 2023, worth a combined $235K — up 19% from $198K a quarter earlier.

Fund positioning in XBIO was balanced in Q1 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 7 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $25.6K. The largest seller was Vanguard Group, cutting an estimated $29.9K.

  • 19 institutional investors held Xenetic Biosciences (XBIO) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $235K of Xenetic Biosciences stock for Q1 2023, up 19% quarter-over-quarter.
  • 2 funds opened new Xenetic Biosciences positions in Q1 2023 and 2 closed out, a net change of 0 holders.
  • The largest Xenetic Biosciences buyer in Q1 2023 was Susquehanna International Group, an estimated $25.6K added.
  • The largest Xenetic Biosciences seller in Q1 2023 was Vanguard Group, an estimated $29.9K sold.

Based on aggregated 13F filings for Q1 2023.